ID GNA13_MOUSE Reviewed; 377 AA. AC P27601; Q6PF99; DT 01-AUG-1992, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1992, sequence version 1. DT 24-JAN-2024, entry version 199. DE RecName: Full=Guanine nucleotide-binding protein subunit alpha-13; DE Short=G alpha-13; DE Short=G-protein subunit alpha-13; GN Name=Gna13; Synonyms=Gna-13; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RX PubMed=1905812; DOI=10.1073/pnas.88.13.5582; RA Strathmann M.P., Simon M.I.; RT "G alpha 12 and G alpha 13 subunits define a fourth class of G protein RT alpha subunits."; RL Proc. Natl. Acad. Sci. U.S.A. 88:5582-5586(1991). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=NMRI; TISSUE=Mammary tumor; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP PROTEIN SEQUENCE OF 51-61 AND 220-227, AND IDENTIFICATION BY MASS RP SPECTROMETRY. RC STRAIN=C57BL/6J; TISSUE=Brain; RA Lubec G., Kang S.U.; RL Submitted (APR-2007) to UniProtKB. RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 228-288. RX PubMed=2508088; DOI=10.1073/pnas.86.19.7407; RA Strathmann M., Wilkie T.M., Simon M.I.; RT "Diversity of the G-protein family: sequences from five additional alpha RT subunits in the mouse."; RL Proc. Natl. Acad. Sci. U.S.A. 86:7407-7409(1989). RN [5] RP INTERACTION WITH CTNND1. RX PubMed=15240885; DOI=10.1073/pnas.0401366101; RA Krakstad B.F., Ardawatia V.V., Aragay A.M.; RT "A role for Galpha12/Galpha13 in p120ctn regulation."; RL Proc. Natl. Acad. Sci. U.S.A. 101:10314-10319(2004). RN [6] RP SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RC TISSUE=Testis; RX PubMed=18703424; DOI=10.1095/biolreprod.107.067504; RA Hu Y., Xing J., Chen L., Guo X., Du Y., Zhao C., Zhu Y., Lin M., Zhou Z., RA Sha J.; RT "RGS22, a novel testis-specific regulator of G-protein signaling involved RT in human and mouse spermiogenesis along with GNA12/13 subunits."; RL Biol. Reprod. 79:1021-1029(2008). RN [7] RP FUNCTION. RX PubMed=19151758; DOI=10.1038/onc.2008.488; RA Lee S.J., Yang J.W., Cho I.J., Kim W.D., Cho M.K., Lee C.H., Kim S.G.; RT "The gep oncogenes, Galpha(12) and Galpha(13), upregulate the transforming RT growth factor-beta1 gene."; RL Oncogene 28:1230-1240(2009). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, RC Pancreas, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [9] RP FUNCTION. RX PubMed=21212405; DOI=10.1161/atvbaha.110.218552; RA Kim Y.M., Lim S.C., Han C.Y., Kay H.Y., Cho I.J., Ki S.H., Lee M.Y., RA Kwon H.M., Lee C.H., Kim S.G.; RT "G(alpha)12/13 induction of CYR61 in association with arteriosclerotic RT intimal hyperplasia: effect of sphingosine-1-phosphate."; RL Arterioscler. Thromb. Vasc. Biol. 31:861-869(2011). RN [10] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 47-377 IN COMPLEX WITH GTP RP ANALOG, FUNCTION, SUBUNIT, AND INTERACTION WITH ARHGEF1 AND ARHGEF12. RX PubMed=16388592; DOI=10.1021/bi051729t; RA Kreutz B., Yau D.M., Nance M.R., Tanabe S., Tesmer J.J., Kozasa T.; RT "A new approach to producing functional G alpha subunits yields the RT activated and deactivated structures of G alpha(12/13) proteins."; RL Biochemistry 45:167-174(2006). RN [11] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 41-377 IN COMPLEX WITH MAGNESIUM, RP AND INTERACTION WITH ARHGEF11. RX PubMed=18940608; DOI=10.1016/j.str.2008.07.009; RA Chen Z., Singer W.D., Danesh S.M., Sternweis P.C., Sprang S.R.; RT "Recognition of the activated states of Galpha13 by the rgRGS domain of RT PDZRhoGEF."; RL Structure 16:1532-1543(2008). RN [12] RP INTERACTION WITH GAS2L2. RX PubMed=23994616; DOI=10.1016/j.bbamcr.2013.08.009; RA Wu Y.C., Lai H.L., Chang W.C., Lin J.T., Liu Y.J., Chern Y.; RT "A novel Galphas-binding protein, Gas-2 like 2, facilitates the signaling RT of the A2A adenosine receptor."; RL Biochim. Biophys. Acta 1833:3145-3154(2013). RN [13] RP INTERACTION WITH GPR174. RX PubMed=31875850; DOI=10.1038/s41586-019-1873-0; RA Zhao R., Chen X., Ma W., Zhang J., Guo J., Zhong X., Yao J., Sun J., RA Rubinfien J., Zhou X., Wang J., Qi H.; RT "A GPR174-CCL21 module imparts sexual dimorphism to humoral immunity."; RL Nature 577:416-420(2020). CC -!- FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved CC as modulators or transducers in various transmembrane signaling systems CC (PubMed:21212405, PubMed:19151758, PubMed:16388592). Activates effector CC molecule RhoA by binding and activating RhoGEFs (ARHGEF1/p115RhoGEF, CC ARHGEF11/PDZ-RhoGEF and ARHGEF12/LARG) (PubMed:16388592). GNA13- CC dependent Rho signaling subsequently regulates transcription factor AP- CC 1 (activating protein-1) (PubMed:19151758, PubMed:21212405). Promotes CC tumor cell invasion and metastasis by activating Rho/ROCK signaling CC pathway (By similarity). Inhibits CDH1-mediated cell adhesion in CC process independent from Rho activation (By similarity). CC {ECO:0000250|UniProtKB:Q14344, ECO:0000269|PubMed:16388592, CC ECO:0000269|PubMed:19151758, ECO:0000269|PubMed:21212405}. CC -!- SUBUNIT: G proteins are composed of 3 units; alpha, beta and gamma CC (PubMed:16388592). The alpha chain contains the guanine nucleotide CC binding site (PubMed:16388592). Interacts with UBXD5 (By similarity). CC Interacts with HAX1 (By similarity). Interacts (in GTP-bound form) with CC PPP5C (via TPR repeats); activates PPP5C phosphatase activity and CC translocates PPP5C to the cell membrane (By similarity). Interacts with CC RGS22 (By similarity). Interacts (in GTP-bound form) with ARHGEF1 CC (PubMed:16388592). Interacts (in GTP-bound form) with ARHGEF11 (via RGS CC domain) (PubMed:18940608). Interacts (in GTP-bound form) with ARHGEF12 CC (via RGS domain) (PubMed:16388592). Interacts with CTNND1 CC (PubMed:15240885). Interacts with GAS2L2 (PubMed:23994616). Interacts CC with GPR35 (By similarity). Interacts with GPR174 (PubMed:31875850). CC {ECO:0000250|UniProtKB:Q14344, ECO:0000269|PubMed:15240885, CC ECO:0000269|PubMed:16388592, ECO:0000269|PubMed:18940608, CC ECO:0000269|PubMed:23994616, ECO:0000269|PubMed:31875850}. CC -!- INTERACTION: CC P27601; O08915: Aip; NbExp=3; IntAct=EBI-2255627, EBI-6935014; CC P27601; Q9ES67: Arhgef11; Xeno; NbExp=3; IntAct=EBI-2255627, EBI-15735216; CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:18703424}; Lipid- CC anchor {ECO:0000269|PubMed:18703424}. Melanosome {ECO:0000250}. CC Cytoplasm {ECO:0000269|PubMed:18703424}. Nucleus CC {ECO:0000269|PubMed:18703424}. Note=Cytoplasmic in adult somatic cells, CC but mainly nuclear in spermatids in the testes. Translocates from the CC cytoplasm to the nucleus during spermatogenesis, hence predominantly CC observed in the cytoplasm of round spermatids but localized in the CC nuclei of elongating or elongated spermatids and testicular CC spermatozoa. CC -!- TISSUE SPECIFICITY: Expressed in brain and testis, as well as in kidney CC and sperm (at protein level). {ECO:0000269|PubMed:18703424}. CC -!- PTM: Phosphorylation on Thr-203 destabilizes the heterotrimer of alpha, CC beta and gamma, and inhibits Rho activation. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the G-alpha family. G(12) subfamily. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M63660; AAA37649.1; -; mRNA. DR EMBL; BC057665; AAH57665.1; -; mRNA. DR EMBL; M57620; AAA63303.1; -; mRNA. DR CCDS; CCDS25577.1; -. DR PIR; B41095; B41095. DR RefSeq; NP_034433.3; NM_010303.3. DR PDB; 1SHZ; X-ray; 2.85 A; A/D=52-159, A/D=333-376. DR PDB; 1ZCB; X-ray; 2.00 A; A=47-377. DR PDB; 3AB3; X-ray; 2.40 A; A/C=47-377. DR PDB; 3CX6; X-ray; 2.50 A; A=41-377. DR PDB; 3CX7; X-ray; 2.25 A; A=41-377. DR PDB; 3CX8; X-ray; 2.00 A; A=41-377. DR PDBsum; 1SHZ; -. DR PDBsum; 1ZCB; -. DR PDBsum; 3AB3; -. DR PDBsum; 3CX6; -. DR PDBsum; 3CX7; -. DR PDBsum; 3CX8; -. DR AlphaFoldDB; P27601; -. DR SMR; P27601; -. DR BioGRID; 199963; 24. DR DIP; DIP-46241N; -. DR IntAct; P27601; 6. DR MINT; P27601; -. DR STRING; 10090.ENSMUSP00000020930; -. DR GlyGen; P27601; 2 sites, 1 O-linked glycan (2 sites). DR iPTMnet; P27601; -. DR PhosphoSitePlus; P27601; -. DR SwissPalm; P27601; -. DR EPD; P27601; -. DR jPOST; P27601; -. DR MaxQB; P27601; -. DR PaxDb; 10090-ENSMUSP00000020930; -. DR PeptideAtlas; P27601; -. DR ProteomicsDB; 267733; -. DR Pumba; P27601; -. DR Antibodypedia; 31626; 304 antibodies from 30 providers. DR DNASU; 14674; -. DR Ensembl; ENSMUST00000020930.14; ENSMUSP00000020930.8; ENSMUSG00000020611.15. DR GeneID; 14674; -. DR KEGG; mmu:14674; -. DR UCSC; uc007mce.1; mouse. DR AGR; MGI:95768; -. DR CTD; 10672; -. DR MGI; MGI:95768; Gna13. DR VEuPathDB; HostDB:ENSMUSG00000020611; -. DR eggNOG; KOG0082; Eukaryota. DR GeneTree; ENSGT00940000157054; -. DR HOGENOM; CLU_014184_3_1_1; -. DR InParanoid; P27601; -. DR OMA; RFACMRC; -. DR OrthoDB; 2897309at2759; -. DR PhylomeDB; P27601; -. DR TreeFam; TF300673; -. DR Reactome; R-MMU-193648; NRAGE signals death through JNK. DR Reactome; R-MMU-416482; G alpha (12/13) signalling events. DR Reactome; R-MMU-428930; Thromboxane signalling through TP receptor. DR Reactome; R-MMU-456926; Thrombin signalling through proteinase activated receptors (PARs). DR Reactome; R-MMU-9013148; CDC42 GTPase cycle. DR Reactome; R-MMU-9013149; RAC1 GTPase cycle. DR BioGRID-ORCS; 14674; 11 hits in 83 CRISPR screens. DR ChiTaRS; Gna13; mouse. DR EvolutionaryTrace; P27601; -. DR PRO; PR:P27601; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; P27601; Protein. DR Bgee; ENSMUSG00000020611; Expressed in rostral migratory stream and 261 other cell types or tissues. DR ExpressionAtlas; P27601; baseline and differential. DR GO; GO:0031526; C:brush border membrane; ISO:MGI. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; ISO:MGI. DR GO; GO:0005834; C:heterotrimeric G-protein complex; ISA:MGI. DR GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0031752; F:D5 dopamine receptor binding; ISO:MGI. DR GO; GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:GO_Central. DR GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW. DR GO; GO:0003924; F:GTPase activity; ISA:MGI. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IGI:MGI. DR GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; IMP:UniProtKB. DR GO; GO:0001525; P:angiogenesis; IMP:MGI. DR GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IMP:MGI. DR GO; GO:0030154; P:cell differentiation; IDA:MGI. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISA:MGI. DR GO; GO:0001701; P:in utero embryonic development; IGI:MGI. DR GO; GO:0035556; P:intracellular signal transduction; IDA:MGI. DR GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; ISO:MGI. DR GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; ISO:MGI. DR GO; GO:0030168; P:platelet activation; IMP:MGI. DR GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:MGI. DR GO; GO:0008217; P:regulation of blood pressure; IGI:MGI. DR GO; GO:0008360; P:regulation of cell shape; IDA:MGI. DR GO; GO:0010762; P:regulation of fibroblast migration; IMP:MGI. DR GO; GO:0007266; P:Rho protein signal transduction; IDA:MGI. DR CDD; cd00066; G-alpha; 1. DR Gene3D; 1.10.400.10; GI Alpha 1, domain 2-like; 1. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1. DR InterPro; IPR000469; Gprotein_alpha_12/13. DR InterPro; IPR001019; Gprotein_alpha_su. DR InterPro; IPR011025; GproteinA_insert. DR InterPro; IPR027417; P-loop_NTPase. DR PANTHER; PTHR10218; GTP-BINDING PROTEIN ALPHA SUBUNIT; 1. DR PANTHER; PTHR10218:SF85; GUANINE NUCLEOTIDE-BINDING PROTEIN SUBUNIT ALPHA-13; 1. DR Pfam; PF00503; G-alpha; 1. DR PRINTS; PR00318; GPROTEINA. DR PRINTS; PR00440; GPROTEINA12. DR SMART; SM00275; G_alpha; 1. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR SUPFAM; SSF47895; Transducin (alpha subunit), insertion domain; 1. DR PROSITE; PS51882; G_ALPHA; 1. DR Genevisible; P27601; MM. PE 1: Evidence at protein level; KW 3D-structure; Cytoplasm; Direct protein sequencing; GTP-binding; KW Lipoprotein; Magnesium; Membrane; Metal-binding; Nucleotide-binding; KW Nucleus; Palmitate; Phosphoprotein; Reference proteome; Transducer. FT CHAIN 1..377 FT /note="Guanine nucleotide-binding protein subunit alpha-13" FT /id="PRO_0000203774" FT DOMAIN 47..377 FT /note="G-alpha" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01230" FT REGION 50..63 FT /note="G1 motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01230" FT REGION 195..203 FT /note="G2 motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01230" FT REGION 218..227 FT /note="G3 motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01230" FT REGION 287..294 FT /note="G4 motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01230" FT REGION 347..352 FT /note="G5 motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01230" FT BINDING 58..63 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000269|PubMed:16388592, FT ECO:0000269|PubMed:18940608, ECO:0007744|PDB:1ZCB, FT ECO:0007744|PDB:3CX6, ECO:0007744|PDB:3CX7" FT BINDING 62 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000269|PubMed:18940608, FT ECO:0007744|PDB:3CX6" FT BINDING 173 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000269|PubMed:18940608, FT ECO:0007744|PDB:3CX7" FT BINDING 197..200 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000269|PubMed:16388592, FT ECO:0000269|PubMed:18940608, ECO:0007744|PDB:1ZCB, FT ECO:0007744|PDB:3CX6, ECO:0007744|PDB:3CX7" FT BINDING 203 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000269|PubMed:18940608, FT ECO:0007744|PDB:3CX6" FT BINDING 291..294 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000269|PubMed:16388592, FT ECO:0000269|PubMed:18940608, ECO:0007744|PDB:1ZCB, FT ECO:0007744|PDB:3CX6, ECO:0007744|PDB:3CX7" FT BINDING 349 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000269|PubMed:16388592, FT ECO:0000269|PubMed:18940608, ECO:0007744|PDB:1ZCB, FT ECO:0007744|PDB:3CX6, ECO:0007744|PDB:3CX7" FT MOD_RES 203 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q14344" FT LIPID 14 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000250|UniProtKB:Q14344" FT LIPID 18 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000250|UniProtKB:Q14344" FT CONFLICT 52 FT /note="L -> P (in Ref. 2; AAH57665)" FT /evidence="ECO:0000305" FT STRAND 49..54 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 61..72 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 78..82 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 85..105 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 113..115 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 116..123 FT /evidence="ECO:0007829|PDB:1ZCB" FT STRAND 127..129 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 130..133 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 139..154 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 156..163 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 164..167 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 174..178 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 181..184 FT /evidence="ECO:0007829|PDB:1ZCB" FT STRAND 185..188 FT /evidence="ECO:0007829|PDB:1SHZ" FT HELIX 193..198 FT /evidence="ECO:0007829|PDB:1ZCB" FT STRAND 204..213 FT /evidence="ECO:0007829|PDB:1ZCB" FT STRAND 216..223 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 227..236 FT /evidence="ECO:0007829|PDB:3CX8" FT STRAND 242..248 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 251..253 FT /evidence="ECO:0007829|PDB:3AB3" FT STRAND 259..263 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 264..276 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 279..281 FT /evidence="ECO:0007829|PDB:1ZCB" FT STRAND 284..291 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 293..299 FT /evidence="ECO:0007829|PDB:1ZCB" FT TURN 300..302 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 305..307 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 319..331 FT /evidence="ECO:0007829|PDB:1ZCB" FT STRAND 343..346 FT /evidence="ECO:0007829|PDB:1ZCB" FT HELIX 352..371 FT /evidence="ECO:0007829|PDB:1ZCB" SQ SEQUENCE 377 AA; 44055 MW; 45A6A6DB47C707BB CRC64; MADFLPSRSV LSVCFPGCVL TNGEAEQQRK SKEIDKCLSR EKTYVKRLVK ILLLGAGESG KSTFLKQMRI IHGQDFDQRA REEFRPTIYS NVIKGMRVLV DAREKLHIPW GDNKNQLHGD KLMAFDTRAP MAAQGMVETR VFLQYLPAIR ALWEDSGIQN AYDRRREFQL GESVKYFLDN LDKLGVPDYI PSQQDILLAR RPTKGIHEYD FEIKNVPFKM VDVGGQRSER KRWFECFDSV TSILFLVSSS EFDQVLMEDR QTNRLTESLN IFETIVNNRV FSNVSIILFL NKTDLLEEKV QVVSIKDYFL EFEGDPHCLR DVQKFLVECF RGKRRDQQQR PLYHHFTTAI NTENIRLVFR DVKDTILHDN LKQLMLQ //